TY - JOUR
T1 - Transitions to injecting drug use among noninjecting heroin users
T2 - Social network influence and individual susceptibility
AU - Neaigus, Alan
AU - Gyarmathy, V. Anna
AU - Miller, Maureen
AU - Frajzyngier, Veronica M.
AU - Friedman, Samuel R.
AU - Des Jarlais, Don C.
PY - 2006/4
Y1 - 2006/4
N2 - Objectives: To determine the incidence/predictors of transitions to injecting among noninjecting heroin users (NIUs). Methods: Street-recruited NIUs in New York City, March/ 1996-March/2003, were interviewed for a prospective cohort study about social network influence (communication promoting injecting; exposure to injectors) and individual susceptibility. A transition to injecting was the first drug injection following baseline. Hazards ratios (HRs) (P < 0.05) were estimated by Cox proportional hazards regression, stratified by baseline injecting history. Results: Of 369 (64% of 579) followed, former-injectors were more likely to transition to injecting (33% or 53/160 vs. 12% or 25/209; 16.0/100 person-years-at-risk [pyar] vs. 4.6/100 pyar; HR = 3.25). Independent predictors among never-injectors included using ≥2 bags of heroin daily (HR = 7.0); social network influence (communication) and homelessness (HR = 6.3); shorter-term heroin use (HR = 5.3); social network influence (exposure) and physically abused (HR = 4.7); friends approve/condone drug injecting (HR = 3.5); lower perceived social distance from injectors (HR = 2.9); and younger age at first heroin use (HR = 1.2). Independent predictors among former-injectors were social network influence (communication) and lower perceived social distance from injectors (HR = 3.4); white race/ ethnicity (HR = 2.0); not very afraid of needles (HR = 1.8); and younger age (HR = 1.1). Conclusions: The risk of initiating injecting was lower than the risk of resuming injecting. Social network influence facilitates transitioning to injecting among those susceptible. Interventions to prevent injecting should address both social network influence and individual susceptibility.
AB - Objectives: To determine the incidence/predictors of transitions to injecting among noninjecting heroin users (NIUs). Methods: Street-recruited NIUs in New York City, March/ 1996-March/2003, were interviewed for a prospective cohort study about social network influence (communication promoting injecting; exposure to injectors) and individual susceptibility. A transition to injecting was the first drug injection following baseline. Hazards ratios (HRs) (P < 0.05) were estimated by Cox proportional hazards regression, stratified by baseline injecting history. Results: Of 369 (64% of 579) followed, former-injectors were more likely to transition to injecting (33% or 53/160 vs. 12% or 25/209; 16.0/100 person-years-at-risk [pyar] vs. 4.6/100 pyar; HR = 3.25). Independent predictors among never-injectors included using ≥2 bags of heroin daily (HR = 7.0); social network influence (communication) and homelessness (HR = 6.3); shorter-term heroin use (HR = 5.3); social network influence (exposure) and physically abused (HR = 4.7); friends approve/condone drug injecting (HR = 3.5); lower perceived social distance from injectors (HR = 2.9); and younger age at first heroin use (HR = 1.2). Independent predictors among former-injectors were social network influence (communication) and lower perceived social distance from injectors (HR = 3.4); white race/ ethnicity (HR = 2.0); not very afraid of needles (HR = 1.8); and younger age (HR = 1.1). Conclusions: The risk of initiating injecting was lower than the risk of resuming injecting. Social network influence facilitates transitioning to injecting among those susceptible. Interventions to prevent injecting should address both social network influence and individual susceptibility.
KW - IDU
KW - Individual susceptibility
KW - Noninjecting heroin users
KW - Risk factors for IDU
KW - Social networks
KW - Transitions to injecting
UR - http://www.scopus.com/inward/record.url?scp=33646786113&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646786113&partnerID=8YFLogxK
U2 - 10.1097/01.qai.0000186391.49205.3b
DO - 10.1097/01.qai.0000186391.49205.3b
M3 - Article
C2 - 16652059
AN - SCOPUS:33646786113
SN - 1525-4135
VL - 41
SP - 493
EP - 503
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
IS - 4
ER -